ETFs
US and ASX exchange-traded funds with their fees, size, holdings and distributions. Each figure shows its source and date; a fund without a public holdings report says why.
General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.
Funds
6,251 funds listed
| Fund | Issuer | Asset class | Expense ratio | Net assets | 12-month yield | Distributions | Holdings |
|---|---|---|---|---|---|---|---|
| ProShares | Equity · US | 0.39%total | $9.3M31 May 2026 | 0.29% | Quarterly | 68 | |
| JPMorgan | Equity · US | 0.40%total | $9.2M30 Jun 2026 | 1.13% | Quarterly | 277 | |
| Direxion | Derivatives-based | 0.97%net | $9.2M31 Jul 2026 | 2.46% | Quarterly | 10 | |
| GraniteShares | Fixed income · US | 1.07%net | $9.2M30 Jun 2026 | 41.52% | Weekly | 7 | |
| Roundhill | Derivatives-based | 0.41%total | $9.2M30 Jun 2026 | No trailing yield | None in 12 months | 8 | |
| REX Shares | Derivatives-based | 1.50%total | $9.2M30 Jun 2026 | No trailing yield | None in 12 months | 3 | |
| Global X | Equity · Global | 0.50%total | $9.2M31 May 2026 | 2.26% | Twice a year | 32 | |
| Matthews | Equity · International | 0.79%total | $9.1M30 Jun 2026 | 2.44% | Quarterly | 64 | |
| AllianzIM | Derivatives-based | 0.74%total | $9.1M31 Jul 2026 | No trailing yield | None in 12 months | 4 | |
| KraneShares | Equity | 1.01%total | $9.1M30 Jun 2026 | 9.07% | Yearly | 3 | |
| PGIM | Derivatives-based | 0.50%total | $9.1M31 Jul 2026 | No trailing yield | None in 12 months | 7 | |
| JPMorgan | Equity · Global | 0.65%total | $9.1M31 Jul 2026 | 0.82% | Twice a year | 61 | |
| Global X | Equity | 0.00%net | $9.1M31 Jul 2026 | 2.08% | Weekly | 3 | |
| Direxion | Derivatives-based | 0.97%net | $9.0M31 Jul 2026 | 1.79% | Quarterly | 10 | |
| Northern Trust | Fixed income · US | 0.18%total | $9.0M30 Jun 2026 | 2.26% | Monthly | 228 | |
| AllianzIM | Derivatives-based | 0.74%total | $9.0M31 Jul 2026 | No trailing yield | None in 12 months | 4 | |
| State Street | Equity · Global | 0.45%total | $8.9M30 Jun 2026 | 0.61% | Quarterly | 57 | |
| Defiance | Derivatives-based | 1.31%total | $8.9M30 Jun 2026 | No trailing yield | None in 12 months | 8 | |
| Direxion | Derivatives-based | No expense ratio found | $8.9M31 Jul 2026 | 1.42% | Quarterly | 9 | |
| Xtrackers (DWS) | Equity · Global | 0.20%total | $8.9M29 May 2026 | 0.60% | Quarterly | 55 | |
| Defiance | Derivatives-based | 1.29%total | $8.8M31 Jul 2026 | 179.96% | Irregular | 10 | |
| USCF | Not classified | 0.45%total | $8.8M30 Jun 2026 | 30.25% | Quarterly | 2 | |
| Global X | Fixed income · US | 0.12%total | $8.8M31 May 2026 | 4.00% | Monthly | 64 | |
| KraneShares | Derivatives-based | 1.26%total | $8.8M30 Jun 2026 | 16.37% | Weekly | 2 | |
| Gabelli | Equity · US | 0.00%net | $8.8M30 Jun 2026 | 0.41% | Irregular | 42 | |
| State Street | Fixed income · US | 0.20%total | $8.7M31 May 2026 | 2.47% | Monthly | 75 | |
| YieldMax | Equity · US | 0.99%total | $8.7M31 Jul 2026 | 12.69% | Monthly | 76 | |
| Global X | Multi-asset · US | 0.75%total | $8.7M31 Jul 2026 | 2.17% | Weekly | 6 | |
| JPMAM / Perpetual | Equity - Global Strategy | 0.40%MER | A$8.7M30 Sep 2026 | 17.46% | Monthly | Holdings unavailable | |
| Issuer not identified | Equity · US | 0.50%total | $8.7M31 Jul 2026 | 1.79% | Quarterly | 36 | |
| First Trust | Derivatives-based | 0.85%total | $8.7M31 May 2026 | No trailing yield | None in 12 months | 4 | |
| iShares | Fixed income · US | 0.18%net | $8.7M31 Jul 2026 | 1.38% | Monthly | 316 | |
| GraniteShares | Fixed income · US | 1.07%net | $8.7M30 Jun 2026 | 117.38% | Weekly | 8 | |
| ProShares | Derivatives-based | 0.95%net | $8.7M31 May 2026 | 3.39% | Quarterly | 9 | |
| State Street | Fixed income · US | 0.15%total | $8.7M31 May 2026 | 4.93% | Monthly | 88 | |
| State Street | Fixed income · US | 0.20%total | $8.6M31 May 2026 | 2.78% | Monthly | 71 | |
| State Street | Fixed income · US | 0.15%total | $8.6M31 May 2026 | 5.23% | Monthly | 118 | |
| Leverage Shares | Derivatives-based | 0.77%total | $8.6M31 Jul 2026 | No trailing yield | None in 12 months | 4 | |
| REX Shares | Derivatives-based | 1.50%total | $8.6M30 Jun 2026 | No trailing yield | None in 12 months | 3 | |
| Virtus | Derivatives-based | 0.86%total | $8.5M31 Jul 2026 | 3.65% | Irregular | 37 | |
| AllianzIM | Derivatives-based | 0.74%total | $8.5M31 Jul 2026 | No trailing yield | None in 12 months | 3 | |
| Global X | Equity | 0.50%total | $8.5M31 May 2026 | 1.52% | Twice a year | 6 | |
| Issuer not identified | Fixed income · US | 0.15%total | $8.5M31 May 2026 | 5.00% | Monthly | 2 | |
| Issuer not identified | Equity · US | 0.81%total | $8.5M29 May 2026 | 1.43% | Quarterly | 51 | |
| ProShares | Derivatives-based | No expense ratio found | $8.5M31 May 2026 | 28.75% | Monthly | 6 | |
| AllianzIM | Derivatives-based | 0.74%total | $8.5M31 Jul 2026 | No trailing yield | None in 12 months | 3 | |
| Tradr | Derivatives-based | 1.49%total | $8.5M30 Jun 2026 | No trailing yield | None in 12 months | 1 | |
| Apostle Dundas / K2 | Equity - Global Strategy | 0.90%MER | A$8.4M30 Sep 2026 | 0.26% | Irregular | Holdings unavailable | |
| Issuer not identified | Equity · US | 0.00%net | $8.4M30 Jun 2026 | 1.34% | Quarterly | 70 | |
| Issuer not identified | Derivatives-based | 0.74%total | $8.4M29 May 2026 | No trailing yield | None in 12 months | 4 |
What this covers
How complete each figure is across the 6,251 listed funds.
- 5,780 US funds from the Nasdaq Trader symbol directory (this includes exchange-traded notes and commodity trusts) and 471 ASX products from ASX's monthly Investment Products report for September 2026.
- Holdings for 4,335 funds. 4,586 US funds have an SEC fund series that files Form N-PORT; funds publish holdings for the last month of each quarter about 60 days later, so the newest holdings shown are as of 31 Aug 2026. ASX funds have no equivalent public report.
- Expense ratios for 4,741 funds. US fees come from each fund's latest prospectus fee table filed with the SEC (newest filing 30 Jun 2026).
- Distribution histories checked for 6,251 funds. Prices are delayed; latest price observed 23 Oct 2026, 15:19 UTC.